Damora Therapeutics (DMRA) Return on Assets (2020 - 2026)

Damora Therapeutics has reported Return on Assets for 7 years, with the latest figure at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, down 1.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.01%, up from 0.02% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q2 2025, with the low at 0.02% in Q4 2025.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
• Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2025, when it slipped 1 bps.
• Damora Therapeutics' Return on Assets stood at 0.01% in 2022, then slipped by 12 bps to 0.01% in 2023, then jumped by 43 bps to 0.0% in 2024, then plunged by 205 bps to 0.02% in 2025, then surged by 62 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.02% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.